Home Clinical Drug Development
Clinical trials present numerous challenges: patient recruitment bottlenecks, complex regulatory requirements, data overload, and unpredictable outcomes. Ardigen’s AI-driven solutions address these hurdles, delivering tools for data analysis, biomarker discovery, and protocol optimization to maximize trial success.
Identify predictive, multimodal biomarkers that enhance patient stratification, improve treatment response predictions, and reduce trial failures.
Utilize LLM-enhanced models to streamline protocol drafting, ensure regulatory compliance, and accelerate study initiation.
Use artificial intelligence to expand inclusion criteria, simulate the impact of recruitment and increase enrollment speed while maintaining clinical rigor.
Integrate diverse data sources into a centralized AI-powered platform, providing predictive insights and risk mitigation strategies.
AI uncovers patterns in multimodal datasets, predicting toxicity risks and improving decision-making at every trial phase.
Automate document drafting, ensure compliance with FDA/EMA guidelines, and reduce submission timelines with AI-driven tools.
Biomarker discovery is key to bridging preclinical models and clinical outcomes. Using human data, AI, and multiomics, we provide predictive insights to optimize trials, enhance decisions, and streamline regulations. Our goal: actionable biomarkers that improve patient outcomes and accelerate development while managing cost and complexity.
Real-time, clear and unified view of the data from your clinical trials. Using single source of truth – data lakehouse – unlocks instant insights for everyone in your organization
Provide comprehensive visualizations, including Swimmer’s Plots, to keep the management well-informed about progress
– Biomarker-driven patient selection
– AI-enhanced protocol design
– Digital twin simulations for in silico trial optimization
– AI-guided patient recruitment & eligibility expansion
– Real-time adverse event monitoring
– Multimodal biomarker profiling for precision medicine
– Automated regulatory submissions with LLMs
– AI-based adaptive trial design
– Predictive models for treatment response & efficacy
Leave us a message and we will reach out to you within 24 hours, to tell you more about how we can empower your drug development journey.
Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!